Intech Investment Management LLC lifted its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 252.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 252,445 shares of the financial services provider's stock after purchasing an additional 180,781 shares during the quarter. Intech Investment Management LLC's holdings in Aflac were worth $26,113,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Whipplewood Advisors LLC bought a new stake in Aflac in the fourth quarter worth $26,000. Darwin Wealth Management LLC bought a new stake in Aflac in the third quarter worth $34,000. BankPlus Trust Department bought a new stake in Aflac in the fourth quarter worth $34,000. Curio Wealth LLC bought a new stake in Aflac in the fourth quarter worth $36,000. Finally, Raelipskie Partnership bought a new stake in Aflac in the third quarter worth $38,000. 67.44% of the stock is owned by hedge funds and other institutional investors.
Aflac Stock Down 0.6 %
AFL traded down $0.61 on Friday, hitting $108.10. The company had a trading volume of 5,333,576 shares, compared to its average volume of 1,994,875. The stock has a fifty day moving average price of $105.95 and a 200-day moving average price of $107.64. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock has a market capitalization of $59.08 billion, a price-to-earnings ratio of 11.26, a P/E/G ratio of 3.24 and a beta of 0.93.
Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.
Insider Transactions at Aflac
In related news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now owns 49,962 shares of the company's stock, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares of the company's stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 55,546 shares of company stock worth $5,863,616. Insiders own 0.80% of the company's stock.
Analysts Set New Price Targets
A number of brokerages recently issued reports on AFL. Evercore ISI lowered their price target on Aflac from $104.00 to $102.00 and set an "underperform" rating for the company in a research report on Wednesday, December 4th. Keefe, Bruyette & Woods lowered their price target on Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a research report on Wednesday, February 12th. Morgan Stanley raised their price target on Aflac from $98.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Wells Fargo & Company decreased their target price on Aflac from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 19th. Finally, Piper Sandler decreased their target price on Aflac from $122.00 to $118.00 and set an "overweight" rating for the company in a research report on Friday, February 7th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Aflac presently has an average rating of "Hold" and an average target price of $103.36.
Check Out Our Latest Report on Aflac
Aflac Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More

Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.